Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1721 - 1728 of 11454 results
Eutelsat/OneWeb Thought Unlikely to Raise US Regulatory Hackles
July 26, 2022| News
Could The FTC Block A Merck-Seagen Merger? M&A Consultant Says No
July 26, 2022| News
Time to Evaluate Your Filer Status for Next Year
July 26, 2022| Advisory| Viewpoint
EEOC Updates Screening, Testing, and Mandatory Vaccination Policies
July 26, 2022| Blog| Viewpoint
ML Strategies Outlook: Federal Action Post-Dobbs Decision
July 25, 2022| Blog| Viewpoint
SEC Tests Its Reach With Coinbase Insider Trading Case
July 25, 2022| News
Judge Albright Holds Willful Infringement Pleading Does Not Require Allegations of Egregious Infringing Behavior
July 22, 2022| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.